Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-Dose AL-60371/AL-817 vs Ciprodex in Acute Otitis Media with Tympanostomy Tubes
NCT01908803Phase 2Terminated
- Sponsor
- Alcon Inc.
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of finafloxacin in acute otitis media (AOM), sponsored by Alcon Inc.. Started Dec 2013; status: terminated.
02
Drugs
finafloxacin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT01908803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908803.